GLOFITAMAB vs GLOFITAMAB-GXBM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLOFITAMAB vs GLOFITAMAB-GXBM: Safety Overview
| Metric | GLOFITAMAB | GLOFITAMAB-GXBM |
|---|---|---|
| Total FAERS Reports | 1,116 | 498 |
| Deaths Reported | 315 | 175 |
| Death Rate | 28.2% | 35.1% |
| Hospitalizations | 492 | 113 |
| Average Patient Age | 62.5 yrs | 60.0 yrs |
| % Female Patients | 53.2% | 36.2% |
| Manufacturer | Genentech, Inc. | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | N/A | Prescription |